Toggle light / dark theme

Wearable sensor metrics, AI, and context

“No one ever made a decision because of a number. They need a story.—Daniel Kahneman.

An essay from WSJ (gift link) https://wsj.com/opinion/when-ai-tells-a-story-about-your-hea…_permalink.

As health-tracking devices (like Oura rings, Whoop bands, and continuous glucose monitors) proliferate and generative AI becomes better at interpreting data, companies promise to turn personal measurements into actionable health insights. However, while AI excels at turning complex, ambiguous data into compelling personalized stories, there is a significant risk that these narrative health insights offer false precision—making recommendations feel far more reliable and individualized than the actual evidence supports.

1. Biology vs. Upstream Metrics.

Just as drug trials targeting specific biomarkers (e.g., lowering inflammation or Lp(a) levels) don’t always reduce overall disease or mortality, tracking upstream metrics (like glucose spikes in non-diabetics or sleep/readiness scores on wearables) often relies on unvalidated formulas with little proof that acting on them improves long-term health.

* AI works spectacularly in constrained biological problems (like AlphaFold predicting protein structures), but predicting holistic human health outcomes remains far more complex.

2. The Danger of AI Storytelling.

* Quoting Daniel Kahneman, “No one ever made a decision because of a number. They need a story.” Generative AI excels at connecting disparate data points (e.g., your HRV, sleep length, workout mileage, and stress levels) into plausible, persuasive narratives.

* The Risk: If we uncritically rely on AI to interpret our numbers and assign meaning to how we feel, we risk surrendering our own agency and ability to make sense of our bodily experiences.

3. A Better Path Forward for AI in Personal Health.

* Mindset & Perception Matter: Citing research by Stanford psychologist Alia Crum (e.g., hotel housekeepers who saw physical health improvements simply by shifting their perception of their daily work as exercise), the author emphasizes that our cognitive framework directly impacts physical outcomes. Here is a summary of the article by Dr. David Shaywitz (published in the *Wall Street Journal•:

Core Premise.

* Just as drug trials targeting specific biomarkers (e.g., lowering inflammation or Lp(a) levels) don’t always reduce overall disease or mortality, tracking upstream metrics (like glucose spikes in non-diabetics or sleep/readiness scores on wearables) often relies on unvalidated formulas with little proof that acting on them improves long-term health.

* AI as a Tool for Mindful Agency: Rather than delivering authoritative, overly definitive judgments on thin evidence, well-designed AI systems should highlight uncertainty, suggest alternative interpretations, and prompt us to examine our own experiences.

* Used correctly, AI can subvert its own narrative fluency to support human judgment—helping individuals become intentional, self-aware authors of their own health decisions rather than passive consumers of algorithmically generated stories.* AI as a Tool for Mindful Agency: Rather than delivering authoritative, overly definitive judgments on thin evidence, well-designed AI systems should highlight uncertainty, suggest alternative interpretations, and prompt us to examine our own experiences.

#ArtificialIntelligence #mindset #DigitalWellness #biomarkers #QuantifiedSelf #DigitalHealth

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */